Papers

3

Total Citations

16

H-Index

2

About

Steven D. Hamilton is a pioneering figure in laboratory automation and high-throughput screening, with foundational contributions to the fields of biotechnology discovery and pharmaceutical research. Working at the intersection of automation technology and molecular biology, Hamilton has dedicated his career to accelerating drug discovery workflows through innovative automation strategies. His landmark 1996 overview of automated biotechnology screening helped establish the conceptual and practical framework for how automation could fundamentally transform analytical and discovery laboratories, moving the field beyond simple productivity gains toward enabling entirely new research paradigms. That same year, his work on automated high-throughput RT-PCR — developed in the context of Amgen's genome project — demonstrated how automation could be harnessed to systematically evaluate gene expression patterns at scale, directly supporting therapeutic target identification. His 1998 review of automation options for plate preparation, cherry picking, and homogeneous assays further cemented his role as a practical guide for laboratories navigating an increasingly complex automation landscape. With a total citation footprint reflecting early-stage but influential work, Hamilton's contributions were instrumental in shaping the infrastructure of modern high-throughput biological research during a critical period of technological transition in the 1990s.

Research Focus

Key Achievements

2
H-Index
3
Papers
16
Total Citations
5
Avg Citations/Paper
🏆 Most Cited Paper
An overview of automated biotechnology screening
9 citations · 1996
📈 Most Prolific Year: 1996 (2 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Amgen (United States), scPharmaceuticals (United States)

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 2 days ago